Srinagar, Nov. 30 -- India stands at a turning point in its battle against HIV/AIDS. Four decades after the first case was reported, the country has built one of the world's most expansive and resilient national HIV prevention and treatment programme. The National AIDS and STD Control Programme (NACP) has shown undeniable gains. New infections have fallen by nearly half since 2010, AIDS-related deaths have dropped by more than 80%, viral suppression now exceeds 97% among those on treatment, and India has transitioned entirely onto Dolutegravir-based regimens-placing it among the global leaders in treatment efficacy. However, there can be no room for complacency. As the country transitions into theNACP Phase-VI (NACP VI)for 2026-31, it mus...